trending Market Intelligence /marketintelligence/en/news-insights/trending/8-d1AWCpxacYLGS6hn_7EQ2 content esgSubNav
In This List

Zimmer Biomet's robot-assisted system gets US FDA approval for spine surgeries

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Zimmer Biomet's robot-assisted system gets US FDA approval for spine surgeries

Zimmer Biomet Holdings Inc. said its robot-assisted system Rosa was approved by the U.S. Food and Drug Administration for spine surgeries.

The Rosa spine system received FDA's 510(k) clearance, which authorizes Zimmer to market the device as safe and effective, or substantially equivalent, to a legally marketed device.

Zimmer Biomet's Rosa spine system provides surgeons tools and real-time data that help improve implant procedures and instrument placement accuracy.

The FDA has also approved the Warsaw, Ind.-based medical device-maker's Rosa systems for brain and knee surgeries.